ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,296.87
0.00%
Dow Jones
39,934.27
0.16%
US Dollar vs MXN
16.6141
-0.40%
Brent Oil
83.52
0.38%
Bitcoin
67,030.49
2.75%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. Mast Therapeutics, Inc. (delisted) (MSTX)

  7. Mast Therapeutics, Inc. (delisted) (MSTX) Noticias

MSTX

Savara Inc. (MSTX)

Mast Therapeutics, Inc. (delisted)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:MSTX
FechaHoraFuenteTítuloSímboloCompañía
13/09/201708:40Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:MSTXMast Therapeutics, Inc. (delisted)
13/09/201708:34Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:MSTXMast Therapeutics, Inc. (delisted)
07/09/201707:51Edgar (US Regulatory)Current Report Filing (8-k)AMEX:MSTXMast Therapeutics, Inc. (delisted)
09/08/201707:48Edgar (US Regulatory)Quarterly Report (10-q)AMEX:MSTXMast Therapeutics, Inc. (delisted)
29/06/201716:00Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:MSTXMast Therapeutics, Inc. (delisted)
29/06/201715:52Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:MSTXMast Therapeutics, Inc. (delisted)
09/06/201709:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:MSTXMast Therapeutics, Inc. (delisted)
06/06/201705:04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:MSTXMast Therapeutics, Inc. (delisted)
11/05/201715:31Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:MSTXMast Therapeutics, Inc. (delisted)
27/04/201715:40Edgar (US Regulatory)(25)AMEX:MSTXMast Therapeutics, Inc. (delisted)
27/04/201715:35Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)AMEX:MSTXMast Therapeutics, Inc. (delisted)
27/04/201715:15PR Newswire (US)Savara Announces Closing Of Merger With Mast TherapeuticsAMEX:MSTXMast Therapeutics, Inc. (delisted)
25/04/201707:01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:MSTXMast Therapeutics, Inc. (delisted)
25/04/201707:00PR Newswire (US)Mast Therapeutics And Savara Announce Anticipated Merger Exchange RatioAMEX:MSTXMast Therapeutics, Inc. (delisted)
21/04/201712:00PR Newswire (US)Mast Therapeutics Announces Adjournment Of Special Stockholders MeetingAMEX:MSTXMast Therapeutics, Inc. (delisted)
20/04/201707:00PR Newswire (US)Mast Therapeutics Announces Possible Adjournment Of Special Stockholders Meeting To Solicit Additional Votes For Merger With ...AMEX:MSTXMast Therapeutics, Inc. (delisted)
17/04/201707:00PR Newswire (US)Mast Reminds Stockholders To Vote For The Proposed Merger With SavaraAMEX:MSTXMast Therapeutics, Inc. (delisted)
11/04/201707:00PR Newswire (US)Leading Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Mast Therapeutics Stockholders Vote "FOR" The Proposed...AMEX:MSTXMast Therapeutics, Inc. (delisted)
10/04/201707:00PR Newswire (US)Mast Therapeutics And Savara Announce Approval To List Common Stock On The Nasdaq Capital MarketAMEX:MSTXMast Therapeutics, Inc. (delisted)
16/03/201707:00PR Newswire (US)Mast Therapeutics Sets Date For Special Meeting Of Stockholders To Vote On Proposed Merger With SavaraAMEX:MSTXMast Therapeutics, Inc. (delisted)
16/03/201705:02Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:MSTXMast Therapeutics, Inc. (delisted)
15/03/201715:37Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:MSTXMast Therapeutics, Inc. (delisted)
13/03/201715:09Edgar (US Regulatory)Confidential Treatment Order (ct Order)AMEX:MSTXMast Therapeutics, Inc. (delisted)
13/03/201705:03Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)AMEX:MSTXMast Therapeutics, Inc. (delisted)
06/03/201715:50Edgar (US Regulatory)Annual Report (10-k)AMEX:MSTXMast Therapeutics, Inc. (delisted)
06/03/201715:30PR Newswire (US)Mast Therapeutics Reports Fourth Quarter And Full Year 2016 Financial ResultsAMEX:MSTXMast Therapeutics, Inc. (delisted)
06/03/201707:00PR Newswire (US)Mast Therapeutics Announces Clinical Study Of AIR001 For The Treatment Of Chronic Infection In Cystic Fibrosis PatientsAMEX:MSTXMast Therapeutics, Inc. (delisted)
10/02/201716:16Edgar (US Regulatory)Securities Registration: Business Combination (s-4)AMEX:MSTXMast Therapeutics, Inc. (delisted)
09/01/201715:25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:MSTXMast Therapeutics, Inc. (delisted)
07/01/201712:00PR Newswire (US)Mast Therapeutics And Savara Sign Merger AgreementAMEX:MSTXMast Therapeutics, Inc. (delisted)
 Showing the most relevant articles for your search:AMEX:MSTX

Su Consulta Reciente

NASDAQ
QQQ
Invesco QQQ Trust Series 1
FX
EURUSD
Euro vs US Dollar
NASDAQ
MSFT
Microsoft
COIN
BTCUSD
Bitcoin
AMEX
SPY
SPDR S&P 500
NYSE
XOM
Exxon Mobil
NYSE
DIS
Walt Disney
NYSE
VZ
Verizon Communications
SPI
SP500
S&P 500
USI
USTECH100
US Tech 100
NYSE
KO
Coca Cola
COIN
SOLUSD
Solana
CCOM
US30
US 30
NYSE
AXP
American Express
NYSE
MCD
McDonalds
NYSE
CVX
Chevron
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados